202 related articles for article (PubMed ID: 9883921)
1. The influence of oral contraceptives on the risk of multiple sclerosis.
Thorogood M; Hannaford PC
Br J Obstet Gynaecol; 1998 Dec; 105(12):1296-9. PubMed ID: 9883921
[TBL] [Abstract][Full Text] [Related]
2. On the epidemiology of oral contraceptives and disease.
Prentice RL; Thomas DB
Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396
[TBL] [Abstract][Full Text] [Related]
3. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.
Beral V; Hermon C; Kay C; Hannaford P; Darby S; Reeves G
BMJ; 1999 Jan; 318(7176):96-100. PubMed ID: 9880284
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
5. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
6. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
7. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
8. Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study.
Vessey M; Mant J; Painter R
Contraception; 1998 Apr; 57(4):231-5. PubMed ID: 9649913
[TBL] [Abstract][Full Text] [Related]
9. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
10. [Oral contraception and circulatory risks].
Wingrave SJ
Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1111-6. PubMed ID: 12266560
[TBL] [Abstract][Full Text] [Related]
11. Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
J R Coll Gen Pract; 1983 Feb; 33(247):75-82. PubMed ID: 6864638
[TBL] [Abstract][Full Text] [Related]
12. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
16. Use of oral contraceptives and risk of breast cancer in young women.
Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L
Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222
[TBL] [Abstract][Full Text] [Related]
17. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
18. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
Schwingl PJ; Ory HW; Visness CM
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
[TBL] [Abstract][Full Text] [Related]
19. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
20. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]